Xarelto is a next generation anti-coagulant (blood thinner) which has been designed to reduce the risk of strokes in patients suffering from deep vein thrombosis, nonvalvular atrial fibrillation and pulmonary embolism. The U.S. Food and Drug Administration (FDA) approved the drug in 2011.
Unfortunately, this drug has been linked to plenty of adverse reactions and severe side effects with the most serious condition being uncontrollable bleeding. Victims who suffered from the complications filed for xarelto claims. Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. have insistently advertised and marketed anticoagulant Xarelto as a safer alternative to the long-time existing medication Warfarin. But the truth was different.
Here’s a list of the commonly reported health issues from Xarelto:
- Unexpected bleeding from gums or nose
- Heavier menstrual bleeding or vaginal bleeding
- Severe bleeding with uncontrollable flow
- Red, pink, or brown urine
- Vomiting blood
- Frequent bleeding and bruising
- Headaches, dizziness or weakness
Lawsuits filed against Xarelto
Precise allegations against the pharmaceutical companies contend that the drug presents an unreasonable risk of injury. Also the drug’s labeling fails to sufficiently warn about its potential side effects. The legal xarelto claims also state that the drug has no known antidote. This is a design defect and that the drug does not provide any greater patient benefits than the existing anticoagulants like warfarin, which were otherwise safely administered for decades.
The lawsuits filed demand that the pharmaceutical giants branded Xarelto as a better anticoagulant despite the reported events of adversities. Doctors and medical staff were allegedly not warned about the risks of the drug or how to medicate a patient in the event of excessive bleeding complications.
The main concern
Internal bleeding is the most serious potential injury Xarelto is known to cause. As of now, there is no potential cure to reverse the loss of blood, apart from emergency dialysis. Patients with severe pulmonary arterial hypertension are more prone to this risk. That being said, not even the emergency dialysis may be sufficient, and a casual gastrointestinal bleed can prove fatal.
The other health hazards include decreased hemoglobin, hip or knee replacement surgery, peripheral edema (swelling of the lower limbs), hematoma (a mass in the blood), and dyspnea which causes difficulty in breathing.
Compensation in a lawsuit
The xarelto claims entitle victims to the following types of damages:
- Past, ongoing and future medical expenses related to Xarelto injuries
- Expenses for surgery, hospitalization, rehabilitation and follow-up care
- Past and future pain and suffering caused from the injuries
- Wage loss of past and future
- Punitive damages, if applicable
More than 20,000 lawsuits are still pending as of May 2018 in federal court against the manufacturers of Xarelto by the victims who have suffered from some form of the injury or other. Xarelto has a very narrow therapeutic index which basically means that it has a too narrow window which can classify it between safe and a dangerous dose. There are also claims from the plaintiffs that the drug should be removed from the market as now the side effects and the probable injuries are known.
Are you suffering?
There are legal firms who would actively investigate cases where Xarelto users have suffered from bleeding from taking the drug. Get in touch with the injury lawyers to determine whether or not your case is eligible for financial settlement, if you or a loved one experienced:
- Severe Internal Bleeding
- Brain Hemorrhaging
- Cerebral Hemorrhaging